
Commercial Update on Indian Chilli industry
We recently announced the successful application of our N-Situ nanoparticle Iron and silica on a commercial chilli farm in Andhra Pradesh, India. The trial was done in collaboration with Mr Venkat Reddy Mekapothula, a large commercial chilli farmer who has reported a 40% increase on

PROFITABLE CHILLI HARVEST USING N-SITU NANO TECHNOLOGY FERTILISER
Globally chillies are produced at a rate of 5.1million tonnes yearly. With demand growing and the valuable crop having a wide variety of uses including food and pharma applications, producers are looking for more ways to increase yield and improve volume. In 2019 Pharm 2

Pharm2farm successful secures a grant for new face mask nano-technology
Pharm2Farm has secured a grant from Innovate UK to develop a highly enhanced anti-viral face mask based on innovative nanoparticles and nanomaterials. The highly competitive application process is yet another seal of approval for Pharm2farms patented nanoparticle capabilities. The project has kicked off and will

International Citrus Greening Trial Gets Underway
The global production of citrus fruit is estimated to be over 1115.6 million tons per year, with the USA producing 8 million tons, at an estimated value of over $3.3 billion. However, these numbers have been in steady decline since 2011. Huanglongbing, commonly referred to

NTU Nanoparticle Spin-Out Launches New Hand Sanitizer to help with COVID-19 Outbreak
Pharm2Farm founded by Dr Gareth Cave, the Head of Inorganic Chemistry at Nottingham Trent University (NTU) has launched a new high alcohol based medical grade hand sanitizer. Pharm2Farm which recently moved to a new facility in Medicity Nottingham produces nanoparticle metal oxides which can be

New Manufacturing Facilities at Nottingham’s MediCity
Pharm2farm has expanded taking on new manufacturing facilities at MediCity, Nottingham which include both office and manufacturing space.

Business Development Manager Hire
Graeme Todd has joined Pharm2Farm as International Business Development Manager and will be promoting the Pharm2Farm technologies across the globe in horticulture, hydroponics, aquaponics and other applications.

Braveheart Completes Further Investment in Pharm2Farm
Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investment group has completed a further investment into Pharm2Farm.

Recent Trials Produce 33% More Basil Leaves
In recent basil growing trials with Korean agricultural group Griin, plants treated with Pharm2Farm’s coated nanoparticle technology produced 33% more leaves over a 20 days harvesting period with a more intense flavour.